For decades, scientists assumed that neural stem cells (NSCs) only occur in the brain and spinal cord. A new international ...

Nick Kharufeh's vision was restored after receiving a stem cell transplant in 2020. He now advocates for the treatment, ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

A new review has found a lack of convincing evidence stem cell injections are helpful for knee osteoarthritis. But there are ...

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Prime Biome is a science-backed probiotic that rejuvenates skin and supports digestion. Learn where to buy Prime Biome ...

The bioenergetic requirements of muscle stem cells (satellite cells ... Depletion of FAO rate-limiting enzyme CPT2 impairs satellite cell mitochondrial respiration and differentiation. CPT2 depletion ...

PARIS, France I March 20, 2025 I Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire ...

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front Paris, ...

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to reset the immune ...